Affordable Access

deepdyve-link deepdyve-link
Publisher Website

A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.

Authors
  • Bryan, Margarette
  • Pulte, E Dianne
  • Toomey, Kathleen C
  • Pliner, Lillian
  • Pavlick, Anna C
  • Saunders, Tracie
  • Wieder, Robert
Type
Published Article
Journal
Investigational New Drugs
Publisher
Springer-Verlag
Publication Date
Dec 01, 2011
Volume
29
Issue
6
Pages
1482–1487
Identifiers
DOI: 10.1007/s10637-010-9478-3
PMID: 20596747
Source
Medline
License
Unknown

Abstract

The data suggest this is a well tolerated regimen with modest response rates but with time to progression and survival rates similar to those reported for paclitaxel alone and relatively high rates of stable disease in this sample of patients.

Report this publication

Statistics

Seen <100 times